Yu Jingwen – Trademark Portfolio

Entity Type: 01

Yu Jingwen holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LARVI and LUMIEASY. The owner is based in Ganzhou City, Jiangxi.

No.6 Niudong village,

Chongxian Township, Xunwu County,

Ganzhou City, Jiangxi 342200 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LUMIEASY
LUMIEASY
Registered 2024
LARVI
LARVI
Registered 2020

Trademark Classifications

Yu Jingwen's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Yu Jingwen have?

Yu Jingwen has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Yu Jingwen file in?

Yu Jingwen files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Yu Jingwen's most well-known trademarks?

Yu Jingwen's registered trademark portfolio includes well-known marks such as LARVI and LUMIEASY. These are among 2 currently registered trademarks in the portfolio.

What is Yu Jingwen's trademark registration success rate?

Yu Jingwen has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.